
PGIMER report bats for new-age targeted lung cancer therapies to be included in AB-PMJAY
New Delhi: A first-of-its-kind report evaluating the cost-effectiveness of new age targeted therapies for lung cancers—one of the top malignancies in the country which is rising at an alarming rate—has suggested including the innovative medicines in India’ …